Nordea Investment Management AB Has $66.14 Million Holdings in Waters Co. (NYSE:WAT)

Nordea Investment Management AB trimmed its holdings in Waters Co. (NYSE:WATFree Report) by 13.2% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 177,495 shares of the medical instruments supplier’s stock after selling 27,015 shares during the period. Nordea Investment Management AB owned about 0.30% of Waters worth $66,136,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors also recently modified their holdings of the business. GAMMA Investing LLC increased its holdings in Waters by 48.0% during the 4th quarter. GAMMA Investing LLC now owns 1,316 shares of the medical instruments supplier’s stock worth $488,000 after purchasing an additional 427 shares in the last quarter. Versant Capital Management Inc increased its stake in shares of Waters by 669.2% during the 4th quarter. Versant Capital Management Inc now owns 200 shares of the medical instruments supplier’s stock worth $74,000 after purchasing an additional 174 shares during the last quarter. IMPACTfolio LLC bought a new stake in Waters in the fourth quarter valued at approximately $207,000. JPMorgan Chase & Co. raised its stake in Waters by 37.2% in the 3rd quarter. JPMorgan Chase & Co. now owns 305,661 shares of the medical instruments supplier’s stock valued at $110,005,000 after acquiring an additional 82,865 shares during the period. Finally, Principal Financial Group Inc. lifted its stake in shares of Waters by 70.7% during the 3rd quarter. Principal Financial Group Inc. now owns 656,019 shares of the medical instruments supplier’s stock worth $236,095,000 after buying an additional 271,804 shares during the last quarter. 94.01% of the stock is currently owned by institutional investors.

Waters Stock Up 0.1 %

Shares of WAT opened at $377.41 on Wednesday. The company has a debt-to-equity ratio of 1.14, a quick ratio of 1.38 and a current ratio of 2.02. Waters Co. has a 52 week low of $279.24 and a 52 week high of $397.02. The stock has a market capitalization of $22.41 billion, a price-to-earnings ratio of 36.01, a PEG ratio of 6.92 and a beta of 1.01. The stock has a fifty day moving average of $375.01 and a 200-day moving average of $344.71.

Waters (NYSE:WATGet Free Report) last posted its earnings results on Friday, November 1st. The medical instruments supplier reported $2.93 EPS for the quarter, beating the consensus estimate of $2.68 by $0.25. The firm had revenue of $740.30 million during the quarter, compared to the consensus estimate of $712.99 million. Waters had a return on equity of 49.93% and a net margin of 21.43%. The business’s quarterly revenue was up 4.0% on a year-over-year basis. During the same period last year, the company earned $2.84 earnings per share. As a group, sell-side analysts anticipate that Waters Co. will post 11.79 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of brokerages have commented on WAT. Deutsche Bank Aktiengesellschaft upped their price objective on Waters from $310.00 to $325.00 and gave the company a “hold” rating in a report on Monday, November 4th. Cfra set a $389.00 price target on shares of Waters in a research report on Thursday, October 17th. Scotiabank started coverage on Waters in a research report on Monday, December 23rd. They set a “sector perform” rating and a $430.00 target price for the company. Evercore ISI boosted their price target on Waters from $335.00 to $355.00 and gave the company an “in-line” rating in a research note on Tuesday, October 1st. Finally, JPMorgan Chase & Co. increased their price objective on shares of Waters from $340.00 to $380.00 and gave the stock a “neutral” rating in a research note on Monday, November 4th. One investment analyst has rated the stock with a sell rating, ten have assigned a hold rating, three have assigned a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat.com, Waters has an average rating of “Hold” and an average target price of $379.71.

Get Our Latest Analysis on WAT

Waters Profile

(Free Report)

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.

Further Reading

Want to see what other hedge funds are holding WAT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Waters Co. (NYSE:WATFree Report).

Institutional Ownership by Quarter for Waters (NYSE:WAT)

Receive News & Ratings for Waters Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters and related companies with MarketBeat.com's FREE daily email newsletter.